Abstract:Efficient therapies for breast cancer remain elusive because of the lack of strategies for targeted transport and receptor-mediated uptake of synthetic drug molecules by cancer cells. Conjugation of nanoparticles (NPs) with active targeting ligands enabling selective molecular recognition of antigens expressed on the surface of cancer cells is promising for localization and treatment of malignant cells. In this study, covalent attachment of synthetic estrogen 17α-ethynylestradiol on the silica (SiO2) shell of silica-gold NPs (SiO2@Au) was undertaken to improve the cancer-targeting ability of the nano-biotags. Chemical and structural analysis of the bioconjugates examined in solution (UV–vis and ξ-potential) and solid state (Fourier transform infrared spectroscopy, X-ray diffractometry, and transmission electron microscopy) confirmed the identity of the carrier particles and surface-bound ligands. The mesoporous silica shell served as a reservoir for anticancer drugs (doxorubicin and quercetin) and to facilitate covalent attachment of receptor molecules by click chemistry protocols. The chemoselective recognition between the nanoconjugates and cell membranes was successfully demonstrated by the accumulation of nanoprobes in the tumor tissue of mice with subcutaneous breast cancer, whereas healthy cells were unaffected. The drug release studies showed sustained release kinetics over several weeks. These findings elaborate the exceptional selectivity and potential of estrogen-coated nano-biolabels in efficient diagnosis and detection of breast cancer cells.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.langmuir.0c02820?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.langmuir.0c02820</a>.TG–DSC of chloroauric acid tetrahydrate; size distribution of the as-prepared Au nanorods and of the shell thickness of mSiO2@Au NPs; UV–vis spectra of quercetin, quercetin-loaded mSiO2@Au NPs and released oxidized quercetin derivate 2-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxybenzofuran-3(2H)-one; calibration curve of quercetin and doxorubicin determined via UV–vis; autofluorescence of MCF-7 breast cancer cells; flow cytometry measurements of E0771 cells, incubated with AF647/Diol-mSiO2@Au NPs; and flow cytometry measurements of control mice treated with PBS (<a class="ext-link" href="/doi/suppl/10.1021/acs.langmuir.0c02820/suppl_file/la0c02820_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Dual-responsive drug carrier based on zeolitic imidazolate framework-8 incorporated into gold nanoparticles/chitosan/copper sulfide for controlled drug delivery

Dual-responsive Nanoparticles for Enhanced Drug Delivery in Breast Cancer Chemotherapy

Multi-Stimuli-Responsive Biocompatible Magnetic Nanocarrier as Drug Delivery System to MCF-7 Breast Cancer Cells

Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH/thermo responsive strategy to breast cancer cells

Hierarchical Nanocarriers for Precisely Regulating the Therapeutic Process via Dual-Mode Controlled Drug Release in Target Tumor Cells

Smart Nanoplatform for Sequential Drug Release and Enhanced Chemo-Thermal Effect of Dual Drug Loaded Gold Nanorod Vesicles for Cancer Therapy.

Facile preparation of a pH-sensitive biocompatible nanocarrier based on magnetic layered double hydroxides/Cu MOFs-chitosan crosslinked к-carrageenan for controlled doxorubicin delivery to breast cancer cells

Nanogram-scale co-delivery of Hesperidin and Bicelin with high performance by Redox- and NIR-responsive nanotheranostic carrier

Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for Ph and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.

Synthesis of quercetin-loaded hyaluronic acid-conjugated pH/redox dual-stimuli responsive poly(methacrylic acid)/mesoporous organosilica nanoparticles for breast cancer targeted therapy

In Vivo Dual-Targeted Chemotherapy of Drug Resistant Cancer by Rationally Designed Nanocarrier.

Stepwise responsive carboxymethyl chitosan-based nanoplatform for effective drug-resistant breast cancer suppression

pH and thermo dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles encapsulated in a copolymer-lipid bilayer.

pH/Redox/Lysozyme-Sensitive Hybrid Nanocarriers With Transformable Size for Multistage Drug Delivery

Receptor-Mediated In Vivo Targeting of Breast Cancer Cells with 17α-Ethynylestradiol-Conjugated Silica-Coated Gold Nanoparticles

Smart Gold-Polymer Nanostructures As Promising Drug Nanocarriers For Dual-Imaging Modality And Synergistic Chemo-Photothermal Therapy in Breast Cancer Cells

Construction of Near-Laser Irradiation Controlled Drug Delivery Platform with Tungsten Disulfide Nanosheets/pH and Thermo-Sensitive Polymer Functionalized Hyper-branched Dendrimer for Anticancer Activity

Microfluidic-Assisted ZIF-Silk-Polydopamine Nanoparticles as Promising Drug Carriers for Breast Cancer Therapy

A facile way to synthesize dual-drug delivery nanocarrier for highly efficient therapy and tracing of intracellular drug release

A convergent fabrication of pH and redox dual-responsive hybrids of mesoporous silica nanoparticles for the treatment of breast cancer

Co-delivery of epirubicin and letrozole using a metal-organic framework nanoparticle in breast cancer therapy